Has AI discovered the next Ozempic? Researchers in Spain race to patent two ... trends now
View
comments
Artificial intelligence has uncovered two plants that provide the same weight loss results as Ozempic, according to a new study.
Researchers at the Catholic University of Murcia in Spain reported that the plants contain similar agonists - a substance mimicking a hormone response - to those in Ozempic.
AI software analyzed thousands of natural compounds that could offer the same weight loss components and eventually narrowed down two plant extracts.
Researchers set out to find a plant alternative due to many individuals experiencing side effects and regaining weight once of the prescription drug.
The team also said that not only would the plants be easier on the body, but they would also be more accessible and cost effective - Ozempic costs about $936 a month.
They are not naming the plant extracts - which for now have been named Compound A and Compound B - until they patent them for a new weight loss drug.
Ozempic’s maker, Novo Nordisk, is preparing to release anew drug, amycretin. Early results from the drug’s safety trial suggest it can help users shed weight twice as quickly as Ozempic
Weight loss drugs surged last year, with Ozempic taking the lead as the most-used option
Ozempic was released in 2017 to treat people with diabetes, but was late found to help people lose weight by suppressing their appetite.
Since been proclaimed as a 'miracle drug,' use of it has by 300 percent in less than three years, with prescriptions hitting nine million in the US as of September 2023.
Morgan Stanley analysts have projected that over the next 10 years, 24 million people - seven percent of the US population - will be taking Ozempic or Wegovy.
